Methscopolamine Bromide

甲溴东莨菪碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMethscopolamine Bromide
Drug Alias NameHyoscine Methobromide溴化甲基东莨菪碱溴甲东莨菪碱溴甲东莨菪硷Pamine Forte +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsNauseaMotion SicknessPeptic Ulcer +[4] 
Global Approved IndicationsNauseaMotion SicknessPeptic Ulcer
Approved Indications in ChinaNauseaMotion SicknessPeptic Ulcer
Original Approved Country/TerritoryUnited States
Original Approved Date1953/04/09
Country/TerritoryUnited StatesHong KongMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBayshore Pharmaceuticals LlcGuangzhou Baiyunshan Guanghua Pharmacy Co Ltd
Inactive CompaniesChinese University Of Hong Kong (Cuhk)Fougera Pharmaceuticals Inc
Active IndicationsNauseaMotion SicknessPeptic Ulcer
Inactive IndicationsColonic Diseases, Functional

Other Information

ATC CodeA03BB03S01FA03
Related LinksWikipediaDrugBankKEGG